Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
A Comprehensive Supply Chain for Core Intermediates in Diabetes Treatment
End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.
Read More →
CDMO vs. Direct Manufacturer: Which Model Fits Your API Strategy?
Drawing from on-the-ground experience in China's top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when ...
Read More →
Case Study: Improving Yield & Purity Through Route Optimization
This case study, based on publicly available academic literature and patents, focuses on the application of synthetic route optimization in improving the yield and purity ...
Read More →
Handling Hazardous Reactions During Intermediate Synthesis
Learn how to manage hazardous reactions during intermediate synthesis with risk assessment, process control, and safety management strategies.
Read More →




